Home

Sonic Healthcare Limited

ASX Code

SHL

Sector

Health Care Equipment & Services

Investor Centre

https://investors.sonichealthcare.com/Investors/

Website

https://www.sonichealthcare.com/

About

Sonic Healthcare is a global healthcare company with a reputation for excellence in laboratory medicine/pathology, radiology/diagnostic imaging and primary care medical services. Headquartered in Sydney, Australia, Sonic has grown to become one of the world’s leading healthcare providers with operations in Australia, the USA, Germany, Switzerland, the United Kingdom, Belgium, Ireland and New Zealand. Sonic’s unwavering commitment to a culture of Medical Leadership has been instrumental in our ongoing operational and financial success. This management philosophy, which values the leadership contribution of medical, scientific and technical specialists, embodies a commitment to honouring the doctor–patient relationship, and allows Sonic to consistently deliver the highest levels of service quality, professionalism and best-practice medical care.

News

Sonic Healthcare lifts dividend despite sharp drop in Covid-related earnings
3 Companies IML Is Backing Whichever Way the Wind Blows
SHL - Credit Suisse rates the stock as Outperform
SHL - Morgans rates the stock as Hold
SHL - Macquarie rates the stock as Neutral
SHL - Morgan Stanley rates the stock as Overweight
Corporate Chit-Chat: BSL; SHL
SHL - Morgan Stanley rates the stock as Overweight
SHL - Morgans rates the stock as Add
Sonic Rides Delta to Record Sales
SHL - Credit Suisse rates the stock as Outperform
SHL - Morgan Stanley rates the stock as Overweight
COVID a Tonic For CSL, Sonic
SHL - Credit Suisse rates the stock as Outperform
Virus Testing Demand Swells Sonic Bottom Line
SHL - UBS rates the stock as Upgrade to Neutral from Sell
SHL - UBS rates the stock as Sell
SHL - UBS rates the stock as Sell
SHL - Credit Suisse rates the stock as Outperform
Recovery Underway For Sonic Healthcare
Sonic Healthcare Shares Move Higher On Reinstated Guidance
SHL - Citi rates the stock as Buy
SHL - UBS rates the stock as Sell